6 months ago
AXGN
AnalystsConstantine DavidesConstantine Davides's Stock Forecasts
AnalystsConstantine Davides
Analyst Ranking
Bottom 1%
#4959 out of 5001 analysts
Average Return
-17.83%
Win Rate
33%35 out of 106
Risk vs Reward
Poor
Good
Constantine Davides's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Optimizerx CorpOPRX | +345.07% | $4.06 | $18.07 | 2024-11-13 - 2025-08-29 | Buy |
Optimizerx CorpOPRX | +227.95% | $5.51 | $18.07 | 2025-02-05 - 2025-08-29 | Buy |
Biovie IncBIVI | +217.17% | $332.00 | $1,053.00 | 2022-03-16 - 2023-03-16 | Strong Buy |
Nanoviricides IncNNVC | +83.91% | $1.31 | $2.40 | 2023-05-31 - 2024-05-31 | Strong Buy |
Optimizerx CorpOPRX | +64.12% | $11.01 | $18.07 | 2025-05-12 - 2025-08-29 | Buy |
Constantine Davides Analyst Color
Get additional color on Constantine Davides's coverage of popular stocks
Constantine Davides's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amn Healthcare Services IncAMN | 11 | Buy | $22.00 | +5.87% | Maintains | 21 days ago |
Optimizerx CorpOPRX | 9 | Buy | $20.00 | +10.68% | Maintains | 22 days ago |
Option Care Health IncOPCH | 6 | Buy | $38.00 | +32.50% | Maintains | a month ago |
Addus Homecare CorpADUS | 4 | Buy | $150.00 | +30.24% | Reiterates | 2 months ago |
Evolent Health IncEVH | 9 | Buy | $13.00 | +34.72% | Reiterates | 2 months ago |
Healthequity IncHQY | 5 | Buy | $117.00 | +30.98% | Maintains | 3 months ago |
Privia Health Group IncPRVA | 4 | Buy | $29.00 | +25.87% | Reiterates | 4 months ago |
U S Physical Therapy IncUSPH | 2 | Buy | $113.00 | +36.33% | Reiterates | 4 months ago |
Axogen IncAXGN | 1 | Buy | $26.00 | +61.09% | Maintains | 6 months ago |
American Tower CorpAMT | 1 | Buy | $248.00 | +21.66% | Maintains | 6 months ago |
Progyny IncPGNY | 2 | Buy | $31.00 | N/A | Maintains | a year ago |
Agilon Health IncAGL | 1 | Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Nemaura Medical IncNMRD | 4 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Nanoviricides IncNNVC | 3 | Strong Buy | $5.25 | N/A | Assumes | 2 years ago |
Scienture Holdings IncSCNX | 2 | Strong Buy | $18.75 | N/A | Maintains | 2 years ago |
Longeveron IncLGVN | 5 | Strong Buy | $125.00 | N/A | Reiterates | 2 years ago |
Electromed IncELMD | 3 | Strong Buy | $15.00 | N/A | Reiterates | 2 years ago |
Innoviva IncINVA | 4 | Strong Buy | $22.50 | N/A | Reiterates | 2 years ago |
Carecloud IncCCLD | 2 | Strong Buy | $8.50 | N/A | Reiterates | 2 years ago |
Hoth Therapeutics IncHOTH | 4 | Strong Buy | $14.00 | N/A | Reiterates | 2 years ago |
Hcw Biologics IncHCWB | 4 | Strong Buy | $360.00 | N/A | Reiterates | 2 years ago |
Bone Biologics CorpBBLG | 3 | Strong Buy | $3,240.00 | N/A | Reiterates | 2 years ago |
Pasithea Therapeutics CorpKTTA | 2 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Acer Therapeutics IncACER | 2 | Strong Buy | $7.00 | N/A | Reiterates | 2 years ago |
Volitionrx LtdVNRX | 2 | Strong Buy | $6.00 | N/A | Reiterates | 2 years ago |
Grace Therapeutics IncGRCE | 2 | Strong Buy | $15.00 | N/A | Reiterates | 3 years ago |
Biovie IncBIVI | 2 | Strong Buy | $800.00 | N/A | Maintains | 3 years ago |
Healthcare Triangle IncHCTI | 2 | Strong Buy | $4,980.00 | N/A | Maintains | 3 years ago |
Ispecimen IncISPC | 2 | Strong Buy | $85.00 | N/A | Maintains | 3 years ago |
Invacare CorpIVCRQ | 1 | Strong Buy | $2.75 | N/A | Initiates Coverage On | 3 years ago |
Tc Biopharm PLCTCBP | 1 | Strong Buy | $8,000,000.00 | N/A | Initiates Coverage On | 3 years ago |
G Medical Innovations Holdings LtdGMVDF | 1 | Strong Buy | $210.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.